-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Day One Biopharmaceuticals, Inc. quarterly Assets, Current history and growth rate from 2020 to 2024.
- Day One Biopharmaceuticals, Inc. Assets, Current for the quarter ending March 31, 2024 was $326 M.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)